Symbiotec Pharmalab Ltd
| Particulars | Jun 2026 | Mar 2026 | Jun 2025 |
|---|---|---|---|
| Revenue | 230.39 | 231.75 | 215.74 |
| Operating Expense | 151.60 | 216.95 | 141.92 |
| Net Profit | 47.01 | -15.69 | 44.51 |
| Net Profit Margin | 20.40% | -6.77% | 20.63% |
| Earning Per Share | 7.49 | -2.73 | 8 |
| EBIDTA | 78.80 | 15.19 | 74.93 |
| Effective Tax Rate | 20.33% | 88.65% | 21.69% |
Particulars
Jun 2026
Revenue230.39
Operating Expense151.60
Net Profit47.01
Net Profit Margin20.40
Earning Per Share7.49
EBIDTA78.80
Effective Tax Rate20.33
